| Entry |
|
|---|
| Name |
Parecoxib sodium (USAN);
Dynastat (TN) |
|---|
| Formula |
C19H17N2O4S. Na
|
|---|
| Exact mass |
392.0807
|
|---|
| Mol weight |
392.41
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
|
|---|
| Remark |
|
|---|
| Efficacy |
Analgesic, Anti-inflammatory, COX-2 inhibitor |
|---|
| Comment |
Active form of prodrug: Valdecoxib [DR: D02709]
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AH Coxibs
M01AH04 Parecoxib
D03717 Parecoxib sodium (USAN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
DG00759 Parecoxib
D03717 Parecoxib sodium
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS2 (COX2)
D03717 Parecoxib sodium (USAN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D03717
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01922 Selective COX2 inhibitor
DG01907 Anti-inflammatory drug, coxibs
DG00759 Parecoxib
Prodrugs [br08324.html]
DG00759
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 27
1 C8y C 37.7300 -18.5500
2 C8y C 37.7300 -19.9500
3 N5x N 39.0600 -20.3700
4 O2x O 39.9000 -19.2500
5 C8y C 39.0600 -18.1300
6 C8y C 36.6100 -17.7100
7 C8y C 34.1600 -16.3100
8 C8x C 34.1600 -17.7100
9 C8x C 35.3500 -18.4100
10 C8x C 36.6100 -16.3100
11 C8x C 35.3500 -15.6100
12 S4a S 32.9700 -15.6100
13 N1b N 31.7100 -14.9100 #-
14 O3c O 33.6700 -14.4200
15 O3c O 32.2700 -16.8000
16 C5a C 30.5200 -15.6100
17 C1b C 29.3300 -14.9100
18 C1a C 28.1400 -15.6100
19 O5a O 30.5200 -17.0100
20 C8y C 36.6100 -20.7900
21 C8x C 34.1600 -20.7900
22 C8x C 34.1600 -22.1900
23 C8x C 35.3500 -22.8900
24 C8x C 36.6100 -22.1900
25 C8x C 35.3500 -20.0900
26 C1a C 39.4800 -16.8000
27 Z Na 31.5000 -12.7400 #+
BOND 28
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 1 5 2
6 1 6 1
7 7 8 2
8 8 9 1
9 9 6 2
10 6 10 1
11 10 11 2
12 7 11 1
13 7 12 1
14 12 13 1
15 12 14 2
16 12 15 2
17 13 16 1
18 16 17 1
19 17 18 1
20 16 19 2
21 2 20 1
22 21 22 2
23 22 23 1
24 23 24 2
25 24 20 1
26 20 25 2
27 21 25 1
28 5 26 1
|
|---|